Urology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Bladder Cancer
Bladder Cancer
FDA Approves First Gene Therapy to Treat High-Risk Form of Bladder Cancer
01/04/2023
The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.
01/04/2023
Urology
Urology
FDA Approves New Option for Complicated UTIs
11/15/2019
The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.
11/15/2019
Urology
Urology
Urothelial Carcinoma Drug Receives FDA Approval
05/18/2017
The FDA has approved a new option for the treatment of patients with locally advanced or metastatic urothelial carcinoma.
05/18/2017
Urology
Urology
FDA Approves New Option for Urothelial Carcinoma
05/09/2017
The FDA has approved a drug for the treatment of patients with with locally advanced or metastatic urothelial carcinoma.
05/09/2017
Urology
Urology
FDA Approves New Treatment for Urothelial Carcinoma
05/01/2017
The FDA granted accelerated approval for a new treatment for patients with locally advanced or metastatic urothelial carcinoma.
05/01/2017
Urology
Urology
FDA Approves New Option for Urothelial Carcinoma
02/03/2017
The FDA has expanded the use of Opdivo (nivolumab) for the treatment of patients with urothelial carcinoma, the most common form of bladder cancer.
02/03/2017